Introduction
In the male mammal in general, and in the male dog in particular, the fine details of the endocrine control of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion are poorly understood. Since the neuroendocrine axis of the male dog has been the subject of very little research, we have been investigating the hypothalamic-pituitary-testicular axis of this species. Over a 24-h period, peaks of LH are followed approximately 50 min later by increases in the plasma concentrations of testosterone (DePalatis, Moore & Falvo, 1978) . This relationship between LH and testosterone, however, was not observed when dogs were examined twice monthly over a 12-month period and indicated that some other hormone may be involved in gonadotrophin regulation in this species (Falvo, DePalatis, Moore, Kepic & Miller, 1980) . Other data have indicated that, in orchidectomized dogs, testosterone replacement within physio¬ logical limits could maintain plasma concentrations of both LH (Vincent, Kepic, Lathrop & Falvo, 1979) and FSH (Falvo & Vincent, 1980) (Jones & Boyns, 1974) Greenwood, Hunter & Glover (1963) as modified by Schanbacher & Ford (1977) .
In brief, 2-5 pg purified ovine FSH was reacted with 0-5 mCi 125I (New England Nuclear) and 2 pg chloramine for 30 sec. Iodinated FSH was separated from free iodide on Bio-Gel P-100 columns. On the day of use, the iodinated preparation was rechromatographed on a microcolumn containing 0-5 g Bio-Rad AG 1X10 anión exchange resin and equilibrated with assay buffer. Binding curves were generated with the canine reference standard (LER-1685-3A) . Diluted FSH antiserum (400 pi, 1:10 000) containing 0-75% normal rabbit serum and 100 pi (10 000 (Kirk, 1968) at the 5% significance level. Since observations were made at baseline (08:00-09:00 h) as well as during the peak periods of steroid treatment, the ANOVA indicated steroid effects with a significant time-by-treatment interaction. That is, a change in hormone levels induced by treatment and observed over part of the 24 h period of observation resulted in a large mean square for the time-by-treatment interaction.
Results
The results of the ANOVA for the response of plasma LH to the various steroid treatments are shown in Table 2 Table 2 . Averaging over the time of day factor, there were significant dog and order effects but no treatment effect. Including the time of day factor showed significant order-by-time and treatment-by-time interaction effects. Not only did order of steroid administration (or total time in the study) affect FSH level, it affected it differently at different periods of observation. As before, the time by treatment interaction indicated a changing FSH level over time for some treatment groups.
The plasma concentrations of FSH throughout the study period are shown in Text- fig. 2 . Using Tukey's range test in comparing responses over time for each treatment, the following effects were noted. Administration of oil and dihydrotestosterone had no effect on plasma FSH. Administration of androstanediol caused a significant reduction in plasma FSH at 3 h after injection when compared to baseline levels. Both testosterone and oestradiol in the post-injection period caused significant reductions in plasma FSH when compared to baseline. Oestradiol administration caused suppression of plasma FSH from 3 h after injection throughout the 24 h period, whereas testosterone suppression was only apparent at 6 and 9 h after injection. (Parvizi, Elsaesser, Smidt & Ellendorff, 1977) . In contrast, dihydrotestosterone has no effect on FSH or LH in the orchidectomized sheep (Schanbacher & Ford, 1977) or dog (present study).
The effects of 5a-androstan-3a,17ß-diol on LH and FSH secretion have not been extensively studied. There are reports indicating suppression ofLH (Martini, Celloti, Massa & Motta, 1978) and FSH (Robaire, 1980) by this androgen in the orchidectomized rat. The results of the present study indicated no effect on LH, but there was a short-lasting suppression of FSH. The data regarding FSH in the present study must be interpreted with caution because the response was small and the sequence of steroid administration may have affected the results.
The present data indicate that testosterone and oestradiol are involved in the control of LH and FSH secretion. Although the 5 -reduction of testosterone to dihydrotestosterone is not involved in this regulatory process, the importance of central versus peripheral aromatization of testosterone to oestradiol in the regulation of gonadotrophin secretion needs to be clarified. Whether testosterone is directly involved in negative feedback or whether its conversion to oestrogens is required for activity remains to be determined. It will be necessary to inhibit selectively both the aromatase and 5a-reductase enzymes to resolve this issue.
